Cannara Biotech Inc. (TSXV:LOVE)

Canada · Delayed Price · Currency is CAD

1.780

-0.020 (-1.11%)

At close: Feb 25, 2026

Revenue by Segment

Financials in millions CAD. Fiscal year is September - August.

Millions CAD. Fiscal year is Sep - Aug.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Aug '25 Aug 31, 2025	Aug '24 Aug 31, 2024	Aug '23 Aug 31, 2023	Aug '22 Aug 31, 2022	Aug '21 Aug 31, 2021	Aug '20 Aug 31, 2020	Aug '19 Aug 31, 2019	Aug '18 Aug 31, 2018
Cannabis Operations	103.02M	77.63M	53.48M	32.61M	13.97M
Cannabis Operations Growth	32.70%	45.16%	64.01%	133.45%	13303.97%
Real Estate Operations	3.84M	4.02M	3.59M	3.37M	3.12M
Real Estate Operations Growth	-4.41%	12.06%	6.38%	8.08%	32.42%
Other	-	-	-	17.60K	178.92K
Other Growth	-	-	-	-90.16%	51.73%
Total	106.86M	81.65M	57.07M	36.00M	17.27M
Total Growth	30.87%	43.08%	58.53%	108.48%	569.54%

Revenue by Geography

Financials in millions CAD. Fiscal year is September - August.

Millions CAD. Fiscal year is Sep - Aug.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Aug '25 Aug 31, 2025	Aug '24 Aug 31, 2024	Aug '23 Aug 31, 2023	Aug '22 Aug 31, 2022	Aug '21 Aug 31, 2021	Aug '20 Aug 31, 2020	Aug '19 Aug 31, 2019	Aug '18 Aug 31, 2018
Canada	107.20M	81.75M	57.26M	35.84M	17.02M
Canada Growth	31.14%	42.77%	59.76%	110.58%	559.98%
Total	107.20M	81.75M	57.26M	35.84M	17.02M
Total Growth	31.14%	42.77%	59.76%	110.58%	559.98%

Source: S&P Global Market Intelligence.